Koyfin Home > Directory > Health Care > Alexion Pharm Inc > EBITDA

Alexion Pharm Inc EBITDA Chart (ALXN)

Alexion Pharm Inc annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Alexion Pharm Inc EBITDA for the quarter ending September 09, 2020 was $846m a 27.21% increase of 230m year over year
  • Alexion Pharm Inc EBITDA for the last 12 months ending September 09, 2020 was $3,105m a 19.59% increase of 608m year over year
  • Alexion Pharm Inc Annual EBITDA for 2019 was $2,496m a 19.89% increase of 497m from 2018
  • Alexion Pharm Inc Annual EBITDA for 2018 was $2,000m a 27.25% increase of 545m from 2017
  • Alexion Pharm Inc Annual EBITDA for 2017 was $1,455m a 19.78% increase of 288m from 2016
Other Income Statement Metrics:
  • Alexion Pharm Inc Net Income for the quarter ending December 12, 2018 was $-45m a 653.56% decrease of -294m year over year
  • Alexion Pharm Inc Total Revenue for the quarter ending December 12, 2018 was $1,129m a 17.53% increase of 198m year over year
View Chart On Koyfin

Quarterly ALXN EBITDA Data

09/2020$846m
06/2020$793m
03/2020$828m
12/2019$616m
09/2019$653m
06/2019$634m
03/2019$594m
12/2018$502m
09/2018$535m
06/2018$526m

Annual ALXN EBITDA Data

2019$2,496m
2018$2,000m
2017$1,455m
2016$1,167m
2015$839m
2014$956m
2013$600m
2012$417m
2011$258m
2010$164m